Article
Toll like receptor 3 expression as a novel predictor of response to treatment in chronic hepatitis C virus patients.
Scandinavian journal of clinical and laboratory investigation - 1 Dec 2011
Hashad Doaa I, Salem Perihan E, Abdallah Dina M
Abstract excerpt
PURPOSE: This work was carried out to study the level of pretreatment hepatic expression of Toll like receptor 3 (TLR3) among chronic HCV patients, aiming to determine if there are consistent differences in gene expression, between those who show complete early virological response (cEVR) at week-12 of Pegylated-Interferon α-2a plus ribavirin treatment and others who are not responding to this combination, also...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
